These trans fatty acids contribute to obesity reduction by decreasing inflammation, improving fat metabolism, and promoting satiety through the release of hormones like cholecystokinin and glucagon-like peptide-1 (75, 76). The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.